NGM Biopharmaceuticals, Inc.

NASDAQ:NGM

1.54 (USD) • At close April 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -27.67-28.797-38.261-47.647-36.437-47.261-46.519-32.45-27.234-28.865-36.692-27.544-27.991-29.765-25.616-19.115-15.941-10.917-7.669-8.26814.165-7.517-3.2-3.941
Depreciation & Amortization 0.5180.5350.5590.6090.6140.5981.3961.4271.4791.4921.5641.5541.5531.6211.651.7311.7671.9421.9351.9611.8911.8791.711.743
Deferred Income Tax -9.18-1.384-1.559000000.9681.0280.9480.570.08-0.018-0.068-0.122000-0.4530000
Stock Based Compensation 6.2966.417.4768.5378.7727.6898.1027.826.5796.3656.7166.5824.1844.0493.7233.6953.6213.0843.6712.6052.5132.9732.2082.268
Change In Working Capital -1.557-4.482-9.488-2.849-3.03110.168-13.861-13.988-2.55110.641-0.81-3.0721.757-1.0491.011-5.419-3.949-0.584-5.364-8.043-9.347-4.856-4.894-4.484
Accounts Receivables -0.0580.7360.5216.323-3.22.294-6.571000006.88200000000000
Change In Inventory 7.58-0.736-0.521-6.3233.2-2.2946.57100000-7.83200000000000
Change In Accounts Payables -1.79-0.931-7.0964.844.888-3.3082.058-0.431-2.3862.491-2.394-2.1288.018-0.234-1.531-5.3434.961.193-1.318-1.1932.516-1.0880.3751.681
Other Working Capital -7.289-3.551-2.392-7.689-7.91913.476-15.919-13.557-0.1658.151.584-0.944-5.311-0.8152.542-0.076-8.909-1.777-4.046-6.85-11.863-3.768-5.269-6.165
Other Non Cash Items 8.630.5541.025-0.477-0.3220.660.7311.4532.424-0.024.964-0.3150.377-0.0030.1190.12-0.099-0.221-0.350.098-2.2141.67-0.113-0.051
Operating Cash Flow -22.963-27.164-40.248-41.827-30.404-28.146-50.151-35.738-18.335-9.359-23.31-22.225-20.04-25.165-19.181-19.11-14.601-6.696-7.777-12.17.008-5.851-4.289-4.465
Investing Activities:
Investments In Property Plant And Equipment -0.188-0.29-0.104-0.67-0.441-0.31-0.822-0.285-0.133-0.196-1.195-0.16-0.274-0.16-0.88-0.565-1.059-0.155-0.509-1.766-0.107-0.674-4.03-1.033
Acquisitions Net 88.159-27.159-24.689-36.311-2.129-35.76315.14400000000000000000
Purchases Of Investments -33.62-22.641-34.706-14.464-100.371-28.438-57.144-86.904-98.9410-49.529-144.996-148.25600-29.399-59.0820-2.49-72.734-30.661-32.703-33.279-36.966
Sales Maturities Of Investments 6149.859.39550.775102.564.2014280.33612152.5222833.99928.7018.99956.83713.75143.77751.99776.99334.2546.628.75768.575
Other Investing Activites -88.15927.15924.68936.3112.12935.763-15.14400000000000000000
Investing Cash Flow 27.19226.86924.58535.6411.68835.453-15.966-6.85321.92652.304-28.724-117.156-114.53128.5418.11926.873-46.3943.62248.9982.4933.48213.223-8.55230.576
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued 0.11101.3850.2792.98433.21819.62400000000000000000
Common Stock Repurchased 00000000000000000000000-0.185
Dividends Paid 000000000000000000000000
Other Financing Activities 1.77501.3850.279-2.26133.21819.6240.6682.3783.4783.324140.47727.6120.9083.4273.5913.5730.643176.538-0.003-1.0581.2070.1630.071
Financing Cash Flow 0.11101.3850.2790.72333.21819.6240.6682.3783.4783.324140.47727.6120.9083.4273.5913.5730.643176.538-0.003-1.0581.2070.163-0.114
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000002.249-2.2490
Net Change In Cash 4.34-0.295-14.278-5.907-27.99340.525-46.493-41.9235.96946.423-48.711.096-106.9594.284-7.63511.354-57.41837.569217.759-9.619.43210.828-14.92725.997
Cash At End Of Period 58.81556.9357.22571.50377.41105.40364.878111.371153.294147.325100.902149.612148.516255.475251.191258.826247.472304.89267.32149.56259.17249.7438.91253.839